Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Podcast

    Legal Innovators Interview Series - The General Counsel At Covis Pharma Discusses The World Of Pharmaceutical Approvals Around The Globe - Corporate Counsel (Podcast)

    On this episode of The Legal Innovators Interview Series podcast, Edward John Allera, shareholder and co-chair of the firm's FDA group and Matthew Fedowitz, shareholder in the firm's IP section...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Legislators And Groups Urge FDA To Require Sex-Specific Data, Labeling In New Action Plan

    Members of Congress and interest groups are pressuring FDA to promote sex-specific clinical research and product labelling.
    United StatesFood, Drugs, Healthcare, Life Sciences
Jones Day
Jones Day
  • Article

    Life Sciences Compliance & Enforcement Webinar Series – Part II: Addressing Whistleblower Complaints In An FDA Regulated Company

    Companies in the drug, biologic and medical device spaces may encounter compliance challenges, some of which can lead to government enforcement actions and potential civil, and even criminal, liability.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley Hoag LLP
    Foley Hoag LLP
  • Article

    Life Sciences Executive Exchange Series Session Two - Protecting And Defending Innovations

    In this series, designed for experienced pharma professionals and executives, Buchanan professionals will tackle critical issues to help you navigate the Pharma Product Lifecycle.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Life Sciences Executive Exchange Series - Webinar Recap

    In this series, designed for experienced pharma professionals and executives, Buchanan professionals will tackle critical issues to help you navigate the Pharma Product Lifecycle.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Podcast

    Life Sciences Investors: Developments To Watch, With Kevin Madagan (Podcast)

    McGuireWoods partner Kevin Madagan offers private equity investors a window into the future of the life sciences industry in this wide-ranging conversation with partner and host Geoff Cockrell.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Video

    Life Sciences MOFORUM (Video)

    The convergence of life sciences and technology continues to have a tremendous impact across the life sciences industry. Innovation is moving at a rapid pace, investment across the sector...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Morrison Foerster
    Morrison Foerster
  • Article

    M&A: The Last Refuge For Biotechs Seeking Funding

    These are tough times in the biotech and pharmaceutical industries: Funding is drying up, investors are fleeing the space, the IPO door is pretty firmly shut, valuations are dropping, activists are lurking and the headlines are anything but kind.
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Article

    Medical Device Connectivity Creates Vulnerabilities

    Networked device innovations have transformed healthcare by empowering patients and providers to more closely monitor health, enhancing quality of life and improving clinical outcomes.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    Medtech Primer On The FDA Regulatory Landscape

    "Medtech companies are subject to FDA regulation as medical device manufacturers if their products satisfy the 'device' definition in the Federal Food, Drug and Cosmetic Act (FDCA).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    MedTech Round Table: What The Trump Administration Means For Companies And Investors

    On Thursday, April 10, 2025, in its Boston office of Foley & Lardner LLP hosted and participated in a MedTech round table of investors and business leaders...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Mobile App Compliance For Dummies: New Tool Helps Developers Understand Their Legal Compliance Requirements

    In a joint effort by the FTC, OCR, HHS Office of National Coordinator for Health Information Technology, and FDA, a new web-based tool has been released that is designed to help developers of mobile health apps understand the multitude of federal laws and regulations that may apply to them.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Mulryne Featured In Legal Women On Maternity Leave During Pandemic Lockdown

    Life Sciences and Healthcare Regulatory partner Jacqueline Mulryne spoke about her experience with maternity leave while quarantining during the coronavirus pandemic
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Myriad's Impact On Nanotechnology? Nanotechnology's Impact On Myriad??

    On April 15, 2013, the Supreme Court will hear oral arguments in the Myriad Genetics v. Association for Molecular Pathology litigation.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Nanomedicine Showing Its Value … And The Press Is Noticing

    The Economist, one of the more worthy media sources these days for connecting technology to larger society, included a page on nanomedicine in its special issue, "The World in 2013." (page 128).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Nanotechnology Will Improve The Energy Conversion Rate Of Solar Cells According to Japanese Researchers

    Under current commercially available solar cell technology, less than 20% of the energy found in sunlight is ultimately converted into electrical energy.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    NANOvember Attracts A Record Crowd

    As previously posted on The Nano Newswire, throughout November, the College of Nanoscale Science and Engineering (CNSE) at the University of Albany is hosting "NANOvember" a month-long celebration of nanotechnology.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    NASEM Will Hold July 17 Webinar On Nanotechnology R&D Infrastructure: Then And Now

    The National Academies of Sciences, Engineering, and Medicine (NASEM) will hold a webinar on July 17, 2025, on "Nanotechnology R&D Infrastructure: Then and Now." NASEM states that...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    NASEM Will Hold Workshop On Synthetic Biology For Biomanufacturing And Predictable Engineering On July 1, 2025

    On July 1, 2025, the National Academies of Sciences, Engineering, and Medicine (NASEM) will hold a workshop session on transformative science and technology...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    Nations Press for International Restrictions to Govern Genetic Sequence Data

    clash over access to and use of genetic sequence data (GSD) is currently brewing on several international fronts. To date, GSD has been routinely deposited in open-source databases such as GenBank of the National Center for Biotechnology Information ..
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Showing 501–520 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics